Brief: Gen Ilac Signs License And Supply Agreement With Sanovel Ilac
16/11/2021 15:22
Nov 16 (Reuters) - GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET AS
GENIL.IS :
* SIGNS LICENSE AND SUPPLY AGREEMENT WITH SANOVEL ILAC FOR INITALLY 10 YEARS
* EXPECTS CONTRIBUTION TO SALES OF CO TO BE AROUND 9.5 MILLION LIRA FOR
2022, 13.5
MILLION LIRA FOR 2023 AND 18.4 MILLION LIRA FOR 2024
* AGREEMENT WILL COVER SALE AND DISTIBUTION OF SOME DRUGS PRODUCED BY
SANOVEL IN
AZERBAIJAN AND UZBEKISTAN
Source text for Eikon: ID:nIKA7w5Qjt
Further company coverage: GENIL.IS
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Gen Ilac ve Saglik Urunleri Sanayi Ticaret
See all newsBrief: Gen Ilac Says It Wins Pharmaceutical Tender In Kazakhstan, Expects $1.19 Million Sales Contribution In 2027
Brief: Gen Ilac Says It Participates In Kazakhstan Drug Procurement Tender Via Med Service Plus Authorized By Kazakhstan Representative Office Of Gen Ilac
Brief: Gen Ilac Says It Signs Supply And Distribution Agreement With Incyte On Oct 9
Brief: Gen Ilac Says It Completes Pharmaceutical Manufacturing Plant Investment In Azerbaijan
Brief: Gen Ilac Says It Is To Start Share Buyback Programme For Max 125 Mln Nominal Shares With Allocated Funds Of 1.5 Bln Lira